MIM
DVAX

Macroview Investment Management’s Dynavax Technologies DVAX Stock Holding History

Macroview Investment Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-181
Closed -$2.02K – 217
2024
Q3 		$2.02K Hold
181
– – ﹤0.01% 481
2024
Q2 		$2.03K Hold
181
– – ﹤0.01% 485
2024
Q1 		$2.25K Hold
181
– – ﹤0.01% 524
2023
Q4 		$2.53K Sell
181
-299
-62% -$4.15K ﹤0.01% 487
2023
Q3 		$7.09K Buy
+480
New +$6.75K 0.01% 332
2022
Q1 		– Sell
-1,266
Closed -$18K – 439
2021
Q4 		$18K Buy
+1,266
New +$20.8K 0.02% 178

Other funds holding DVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macroview Investment Management's DVAX Position: Q4 2024 in Review

Macroview Investment Management sold out of Dynavax Technologies (DVAX) in Q4 2024, closing a stake of 181 shares — an estimated $2.02K sold.

Macroview Investment Management first reported a position in DVAX in Q4 2021 and held it in 6 quarters. The position peaked at $18K in Q4 2021. 256 funds tracked by Wall St. Rank hold DVAX as of Q4 2024.

  • Macroview Investment Management reported no remaining Dynavax Technologies position as of Q4 2024 after selling out during the quarter.
  • Macroview Investment Management sold 181 Dynavax Technologies shares in Q4 2024, an estimated $2.02K.
  • Macroview Investment Management first reported a position in Dynavax Technologies in Q4 2021 and held it in 6 quarters.
  • Macroview Investment Management's Dynavax Technologies position peaked at $18K in Q4 2021.
  • 256 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2024.

Based on Macroview Investment Management's 13F filing for Q4 2024, filed 31 Jan 2025.